Ferroptosis-related proteins ALOX15 and HMOX1 are upregulated and associated with inflammation in patients with diabetic nephropathy: a prospective cross-sectional study
- PMID: 41379387
- DOI: 10.1007/s11255-025-04949-6
Ferroptosis-related proteins ALOX15 and HMOX1 are upregulated and associated with inflammation in patients with diabetic nephropathy: a prospective cross-sectional study
Abstract
Purpose: To delineate the renal expression of ferroptosis-driving proteins ALOX15 and HMOX1 in DN and to determine their relationship with intra-renal inflammatory activity.
Methods: In this prospective, single-centre cross-sectional study, 150 consecutive biopsy-proven DN patients and 150 age- and sex-matched type 2 diabetes mellitus (T2DM) controls without nephropathy were enrolled between April 2021 and April 2025. After identifying the intersection of ferroptosis- and DN-related transcriptomic signatures by integrative bioinformatics, Kyoto Encyclopaedia of Genes and Genomes (KEGG) pathway enrichment was performed. Demographics, routine biochemistry and concurrent inflammatory indices were captured. Serum concentrations of ALOX15, HMOX1, IL-1β, IL-6 and TNF-α were quantified in duplicate by validated high-sensitivity ELISA.
Results: Compared with T2DM controls, DN patients exhibited a longer diabetes duration, higher fasting plasma glucose (FBG), glycated haemoglobin (HbA1c), serum creatinine (Scr), blood urea nitrogen (BUN) and urine albumin-to-creatinine ratio (UACR), and a markedly lower estimated glomerular filtration rate (eGFR) (all P < 0.05). Circulating ALOX15 and HMOX1 were significantly elevated in DN (both P < 0.05). Multivariable logistic regression identified increased Scr, UACR, ALOX15 and HMOX1, together with reduced eGFR, as independent risk factors for DN (all P < 0.05). ROC analysis revealed AUCs of 0.750, 0.726 and 0.881 for ALOX15 alone, HMOX1 alone and their combination, respectively, in predicting DN. Both ferroptosis markers correlated positively with IL-1β, IL-6 and TNF-α (all P < 0.001).
Conclusion: ALOX15 and HMOX1 are markedly up-regulated in DN and tightly linked to systemic inflammation. Their combined quantification offers robust diagnostic performance and positions these ferroptosis executors as candidate therapeutic targets for early interception of DN.
Keywords: ALOX15; Diabetic nephropathy; HMOX1; Inflammatory cytokines; Type 2 diabetes mellitus.
© 2025. The Author(s), under exclusive licence to Springer Nature B.V.
Conflict of interest statement
Declarations. Conflict of interest: The authors declare no competing interests. Ethical approval: This study involving human participants was conducted in accordance with the Declaration of Helsinki and received ethical approval from the Bethune International Peace Hospital (Approval Number: 2021-KY-16). Written informed consent was obtained from all participants, ensuring their confidentiality and anonymity throughout the research process.
Comment in
-
Comment on "Ferroptosis-related proteins ALOX15 and HMOX1 are upregulated and associated with inflammation in patients with diabetic nephropathy: a prospective cross-sectional study".Int Urol Nephrol. 2026 Jan 14. doi: 10.1007/s11255-026-05013-7. Online ahead of print. Int Urol Nephrol. 2026. PMID: 41533283 No abstract available.
References
-
- Gaddy A, Elrggal M, Madariaga H, Kelly A, Lerma E, Colbert GB (2025) Diabetic kidney disease. Dis Mon 71(4):101848. https://doi.org/10.1016/j.disamonth.2024.101848 - DOI - PubMed
-
- Hu Q, Jiang L, Yan Q, Zeng J, Ma X, Zhao Y (2023) A natural products solution to diabetic nephropathy therapy. Pharmacol Ther 241:108314. https://doi.org/10.1016/j.pharmthera.2022.108314 - DOI - PubMed
-
- Huang TS, Wu T, Wu YD, Li XH, Tan J, Shen CH, Xiong SJ, Feng ZQ, Gao SF, Li H, Cai WB (2023) Long-term statins administration exacerbates diabetic nephropathy via ectopic fat deposition in diabetic mice. Nat Commun 14(1):390. https://doi.org/10.1038/s41467-023-35944-z - DOI - PubMed - PMC
-
- Wang H, Liu D, Zheng B, Yang Y, Qiao Y, Li S, Pan S, Liu Y, Feng Q, Liu Z (2023) Emerging role of ferroptosis in diabetic kidney disease: molecular mechanisms and therapeutic opportunities. Int J Biol Sci 19(9):2678–2694. https://doi.org/10.7150/ijbs.81892 - DOI - PubMed - PMC
-
- Long Z, Luo Y, Yu M, Wang X, Zeng L, Yang K (2024) Targeting ferroptosis: a new therapeutic opportunity for kidney diseases. Front Immunol 15:1435139. https://doi.org/10.3389/fimmu.2024.1435139 - DOI - PubMed - PMC
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
